Product NDC: | 0168-0268 |
Proprietary Name: | Betamethasone Dipropionate |
Non Proprietary Name: | betamethasone dipropionate |
Active Ingredient(s): | .5 mg/g & nbsp; betamethasone dipropionate |
Administration Route(s): | TOPICAL |
Dosage Form(s): | OINTMENT, AUGMENTED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0168-0268 |
Labeler Name: | E. FOUGERA & CO., A division of Fougera Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075373 |
Marketing Category: | ANDA |
Start Marketing Date: | 19990622 |
Package NDC: | 0168-0268-15 |
Package Description: | 15 g in 1 TUBE (0168-0268-15) |
NDC Code | 0168-0268-15 |
Proprietary Name | Betamethasone Dipropionate |
Package Description | 15 g in 1 TUBE (0168-0268-15) |
Product NDC | 0168-0268 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | betamethasone dipropionate |
Dosage Form Name | OINTMENT, AUGMENTED |
Route Name | TOPICAL |
Start Marketing Date | 19990622 |
Marketing Category Name | ANDA |
Labeler Name | E. FOUGERA & CO., A division of Fougera Pharmaceuticals Inc. |
Substance Name | BETAMETHASONE DIPROPIONATE |
Strength Number | .5 |
Strength Unit | mg/g |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |